Enable AccessibilityEnable Accessibility

Expanding Neglected Patient’s Access to Quality Diagnosis and Treatment in Disease-Endemic Countries

Equipping facilities with safe, effective tools, training primary health workers, and supporting community awareness and behaviors.

The Program

Partner: DNDi (Drugs for Neglected Diseases initiative)
Budget: 1 billion yen
Term: 5 years
Launch: 2019
Area: 16 countries across Africa, Asia, and South America

DNDi Website

Over 1 billion people, including 500 million children, are affected by Neglected Tropical Diseases (NTDs), a group of diseases that disproportionally prevail in tropical and subtropical countries. DNDi targets five NTDs: sleeping sickness, Chagas disease, leishmaniasis, onchocerciasis and mycetoma. These are characterized by significant morbidity and/or mortality and have been prioritized due to the current limited availability and accessibility of effective diagnostic and treatment.



Related Content